Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease
PHASE3
This study evaluates the efficacy and safety of ombitasvir/paritaprevir/rit...
A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis C
PHASE3
The purpose of this study is to evaluate the safety and antiviral activity ...
Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, Β± Dasabuvir, Β± Ribavirin in Patients With Chronic Hepatitis C - An Observational Study in Germany (LIFE-C)
N/A
The interferon-free combination regimen of paritaprevir/r - ombitasvir with...
Status
Completed
Location
Multiple Locations
Start Date
2015-12-03
Trial ID
NCT02615145
Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected Adults
PHASE2
To evaluate the effect of ribavirin on second phase plasma hepatitis C viru...